Sign In
Buy EDIT
$2.78
-0.0400 (-1.42%)
At Close: Jun 03, 2026
Beam Therapeutics Taking Novel Approach to Gene Therapy
10:21pm, Monday, 18'th May 2020
Company shares up substantially since early February IPO Continue reading...
Editas Medicine, Inc. (EDIT), a leading genome editing company, today announced results from a pre-clinical study evaluating multi-gene knockout and transgene knock-in using its proprietary engineered
The 3 Best Biotech Stocks to Own in 2020
02:37pm, Thursday, 14'th May 2020
By 2024, the biotech sector could rocket to $775 billion with plenty of long-term growth catalysts. And that's great news for biotech stocks.
Detection in one hour, as sensitive as PCR test: Debojyoti Chakraborty
06:51pm, Tuesday, 12'th May 2020
Senior scientist Dr Debojyoti Chakraborty, who has developed Feluda along with Dr Souvik Maiti, spoke to Sanchita Sharma about test strip.
Low-cost ‘Feluda’ test to detect virus in an hour likely in 4 weeks
06:42pm, Tuesday, 12'th May 2020
Called Feluda, the test is named after a fictional detective created by the late Satyajit Ray, although it is also an acronym for FNCAS9 Editor-Linked Uniform Detection Assay.
Caribou Biosciences Appoints Cherry Thomas, MD as Senior Vice President of Clinical Development
12:00am, Monday, 11'th May 2020
Caribou Biosciences, Inc., a leading CRISPR genome editing company, today announced the appointment of Cherry Thomas, MD, as Senior Vice President of
Editas Medicine, Inc. (NASDAQ:EDIT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
01:28pm, Sunday, 10'th May 2020
It's been a pretty great week for Editas Medicine, Inc. (NASDAQ:EDIT) shareholders, with its shares surging 11% to...
Editas' (EDIT) Earnings Beat in Q1, Revenues Improve Y/Y
04:38pm, Friday, 08'th May 2020
Editas (EDIT) beats on earnings in the first quarter of 2020 while revenues slightly miss estimates.
U.S. RESEARCH ROUNDUP-Becton Dickinson, Epam Systems, PayPal Holdings
11:36am, Friday, 08'th May 2020
Wall Street securities analysts on Friday revised their ratings and price targets on several
U.S.-listed companies, including Becton Dickinson, Epam Systems and PayPal Holdings.
HIGHLIGHTS
Editas Medicine, Inc. (EDIT) Q1 2020 Earnings Call Transcript
11:30am, Friday, 08'th May 2020
Image source: The Motley Fool. Editas Medicine, Inc. (NASDAQ: EDIT)Q1 2020 Earnings CallMay 7, 2020, 8:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remark
UPDATE 1-Brazil 2020 beef exports undeterred by novel coronavirus - Abiec
07:01pm, Thursday, 07'th May 2020
Brazilian beef exports in 2020 will likely set a new record in terms of volume and value despite the novel coronavirus pandemic, Antônio Camardelli, president of beef group Abiec, said on Thursday.
Editas Medicine (EDIT) Reports Q1 Loss, Lags Revenue Estimates
02:15pm, Thursday, 07'th May 2020
Editas (EDIT) delivered earnings and revenue surprises of 11.54% and -3.82%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Editas Medicine, Inc. (EDIT) CEO Cynthia Collins on Q1 2020 Results - Earnings Call Transcript
02:11pm, Thursday, 07'th May 2020
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2020 Results Earnings Conference Call May 7, 2020, 08:00 AM ET Company Participants Mark Mullikin - Mark Mullikin, Vice P
Editas Medicine Announces First Quarter 2020 Results and Update
11:00am, Thursday, 07'th May 2020
Editas Medicine, Inc. (EDIT), a leading genome editing company, today reported business highlights and financial results for the first quarter of 2020. “The COVID-19 pandemic has given rise to unpr
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
